A new target for treating intervertebral disk degeneration: gut microbes
Frontiers in Microbiology · 29.11.2024 · 15
DOI: 10.3389/fmicb.2024.1452774 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 29.11.2024. Verfasst von Kaizhong Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Intervertebral disk degeneration (IDD) is a common clinical spinal disease and one of the main causes of low back pain (LBP). Generally speaking, IDD is considered a natural degenerative process with age. However, with the deepening of research, people have discovered that IDD is not only related to age, but also has many factors that can induce and accelerate its progression. In addition, the pathogenesis of IDD remains unclear, resulting in limited traditional treatment methods that cannot effectively prevent and treat IDD. Conservative treatment may lead to patients’ dependence on drugs, and the pain relief effect is not obvious. Similarly, surgical treatment is highly invasive, with a longer recovery time and a higher recurrence rate. With the deepening of exploration, people have discovered that intestinal microorganisms are an important symbiotic microbial community in the human body and are closely related to the occurrence and development of various diseases. Changes in intestinal microorganisms and their metabolites may affect the body’s inflammatory response, immune regulation, and metabolic processes, thereby affecting the health of the intervertebral disk. In this context, the gut microbiota has received considerable attention as a potential target for delaying or treating IDD. This article first introduces the impact of gut microbes on common distal organs, and then focuses on three potential mechanisms by which gut microbes and their metabolites influence IDD. Finally, we also summarized the methods of delaying or treating IDD by interfering with intestinal microorganisms and their metabolites. Further understanding of the potential mechanisms between intestinal microorganisms and IDD will help to formulate reasonable IDD treatment strategies to achieve ideal therapeutic effects.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedics, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
- Key Laboratory of Molecular Mechanism for Repair and Remodeling of Orthopedic Diseases, Dalian, Liaoning, China.
- Musculoskeletal Research Laboratory, Department of Orthopedics & Traumatology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
- Dalian Innovation Institute of Stem Cell and Precision Medicine, Dalian, Liaoning, China.
Zitieren
APA
Wang, K., Liu, X., Huang, H., Suo, M., Wang, J., Liu, X., Zhang, J., Chen, X., & Li, Z. (2024). A new target for treating intervertebral disk degeneration: gut microbes. Frontiers in Microbiology, 15. https://doi.org/10.3389/fmicb.2024.1452774
Vancouver
Wang K, Liu X, Huang H, Suo M, Wang J, Liu X, et al. A new target for treating intervertebral disk degeneration: gut microbes. Frontiers in Microbiology. 2024;15. doi:10.3389/fmicb.2024.1452774
BibTeX
@article{Wang2024,
author = {Wang, Kaizhong and Liu, Xiangyan and Huang, Huagui and Suo, Moran and Wang, Jinzuo and Liu, Xin and Zhang, Jing and Chen, Xin and Li, Zhonghai},
title = {A new target for treating intervertebral disk degeneration: gut microbes},
journal = {Frontiers in Microbiology},
year = {2024},
volume = {15},
doi = {10.3389/fmicb.2024.1452774}
}
EUVIMED